Cocaine Abuse and ADHD - 10

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Flupenthixol

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000275

NIDA-09236-10

P50-09236-10

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of buproprion in treating individuals with adult attention-deficit hyperactivity disorder (ADHD) and cocaine dependence.

Sex: All

Ages: 18 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.